Regulatory Issues of Mushrooms as Functional Foods and Dietary Supplements: Safety and Efficacy

Mushrooms as Functional Foods

Volumn , Issue , 2009, Pages 199-226

  Wasser, Solomon P ^a   Akavia, Eden ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Dietary supplement types safety and diversity; Mushroom fruit body composition variability; Mushrooms as functional foods regulatory issues

Indexed keywords

EID: 84889407545     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470367285.ch6     Document Type: Chapter

References (74)

1. Alkerele, O. (1992). Summary of WHO guidelines for the assessment of herbal medicines. Fitoterapia, 62, 99-110.
2. Australia New Zealand Food Authority (ANZFA) (2002). Initial assessment report (prepare a new proposal-section 21). Proposal P235. Review of food-type dietary supplements. Available: www.foodstandards.gov.au/ srcfiles/P235 IA Report v2.pdf. Accessed Oct. 16, 2007.
3. Blumenthal, M. (1999). Regulatory models for approval of botanicals as traditional medicines. In Botanical Medicine. Eshkinazi, D., editor. New York: Mary Ann Liebert, pp. 205-212.
4. Blumenthal, M. (2001). House committee on the government reform holds hearings on dietary supplements. HerbalGram, 52, 55-56.
5. Boa, E. (2004). Wild Edible Fungi: A Global Overview of Their Use and Importance to People. Available: www.fao.org/docrep/007/y5489e/y5489e00.htm. Accessed Oct. 16, 2007.
6. Bresinsky, A. and Besl, H. (1990). A Colour Atlas of Poisonous Fungi. London: Wolfe Publishing.
7. Buchalo, A. S. (1988). Higher Basidiomycetes in Pure Culture. Kiev: Naukova Dumka, p. 133.
8. Canadian Food Inspection Agency (CFIA) (2003). Guide to Food Labelling and Advertising. Available: http://www.inspection.gc.ca/english/fssa/labeti/guide/toce.shtml. Accessed June 10, 2008.
9. Center for Food Safety and Applied Nutrition (CFSAN) (2005a). Food and Drug Administration. Dietary supplements: Overview. Available: http://www.cfsan.fda.gov/3/4 dms/supplmnt.html. Accessed Apr. 14, 2005.
10. Center for Food Safety and Applied Nutrition (CFSAN) (2005b). Food and Drug Administration. Guidance for industry: A dietary supplement labeling guide. Available: http://www.cfsan.fda.gov/3/4dms/supplmnt.html. Accessed Oct. 16, 2007.
11. Chang, S. T. (1999). World production of edible and medicinal mushrooms in 1997 with emphasis on Lentinus edodes (Berk.) Sing. in China. International Journal of Medicinal Mushrooms, 1, 291-301.
12. Chang, S. T. (2001). A 40-year journey through bioconversion of lignocellulosic wastes to mushrooms and dietary supplements. International Journal of Medicinal Mushrooms, 3, 299-311.
13. Chang, S. T. (2006). The need for scientific validation of culinary-medicinal mushroom products. International Journal of Medicinal Mushrooms, 8, 187-195.
14. Chang, S. T. and Buswell, J. A. (1996). Mushroom nutriceuticals. World Journal of Microbiology and Biotechnology, 12, 473-476.
15. Chang, S. T. and Buswell, J. A. (1999). Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (Aphyllophoromycetideae)-A mushrooming medicinal mushroom. International Journal of Medicinal Mushrooms, 1, 139-146.
16. Chang, S.T. and Buswell, J. A. (2003). Medicinal mushrooms-A prominent source of nutriceuticals for the 21st century. Current Topics in Nutraceutical Research, 1, 257-280.
17. Chang, S. T. andMiles, P. G. (2004). Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact. Boca Raton, FL: CRC Press, p. 451.
18. Chihara, G., Hamuro, J., Maeda, Y. Y., Arai, Y., and Fukoka, F. (1970). Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Research, 30, 2776-2781.
19. Cook, J. D., Dassenko, S. A., and Whittaker, P. (1991). Calcium supplementation: Effect on iron absorption. American Journal of Clinical Nutrition, 53, 106-111.
20. Council for Responsible Nutrition (CRN) (2002). TABD dietary supplements. A report from the CEOs on their expert group agreements. Available: www.crnusa.org/pdfs/ TABD0302final.pdf. Accessed Oct. 16, 2007.
21. Council for Responsible Nutrition. (2007). Available: http://www.crnusa.org/. Accessed Oct. 16, 2007.
22. Court of Justice of the European Communities (CURIA) (2005). The court confirms the validity of the community directive on food supplements. Press Release, 66/05. Available: http://curia.europa.eu/en/actu/communiques/cp05/aff/cp050066en.pdf. Accessed Oct. 16, 2007.
23. EUROPA (2003). Commission proposes common rules for adding vitamins and minerals to foods. Press release, IP/03/1516. Available: europa.eu/rapid/pressReleasesAction.do? reference D IP/03/1516&format D HTML&aged D 0&language D EN&guiLanguage D en. Accessed Oct. 16, 2007.
24. European Commission (EC) (2006). Food and feed safety. Regulation on health and nutritional claims. Available: http://ec.europa.eu/food/food/labellingnutrition/claims/index en.htm. Accessed June 10, 2008.
25. Flammer, R. (1980). Differentialdiagnose der Pilzvergiftungen. Stuttgart: Gustav Fischer Verlag.
26. Flammer, R. (1983). Hamolise bei pilzvergiftungen: Fakten and hypothesen. Schweizerische Medizinische Wochenschrift, 113, 1555-1561.
27. Food and Agriculture Commission (FAO) (2005). CODEX STAN 1-1985 (Rev. 1-1991), updated 2005. General standard for the labelling of prepackaged foods. FAO: Codex Alimentarius, 2005.
28. Food and Nutrition Board (1989). Recommended Dietary Allowances, 10th ed.Washington: National Academy Press.
29. Food Standards Australia New Zealand (FSANZ) (2006). FSANZ food standards development work plan. Available: www.foodstandards.gov.au/srcfiles/Workplan9November 2006.doc. Accessed Oct. 16, 2007.
30. Fries, J. F. and Crapo, M. L. (1981). Vitality and Aging: Implications of the Rectangular Curve. San Francisco: W. H. Freeman.
31. Gunde-Cimerman, N. (1999). Medicinal value of the genus Pleurotus (Fr.) P. Karst. (Agaricales, Basidiomycetes). International Journal of Medicinal Mushrooms, 1, 69-80.
32. Hecht, E. (2003). Seller beware: What do tough European supplement laws say about safety in the US Available: findarticles.com/p/articles/mim0FKA/is365/ai97823105. Accessed Oct. 16, 2007.
33. Herbal Medicinal Products Committee (CMPC) (2006). Human Medicines-Herbal Medicinal Products. HMPC Status Report, October 2006. Available: http://www.emea. europa.eu/htms/human/hmpc/hmpcstatus.htm. Accessed June 10, 2008.
34. Hiramoto, K., Kaku, M., Kato, T., and Kikugawa, K. (1995). DNA strand breaking by the carbon-centered radical generated from 4-(hydroxymethyl) benzenediazonium salt, a carcinogen in mushroom Agaricus bisporus. Chemico-Biological Interactions, 94, 21-36.
35. Hobbs, C. (1995). Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture. Santa Cruz: Botanica, p. 251.
36. Huxtable, R. H. (1992). The toxicology of alkaloids in foods and herbs. In Handbook of Natural Toxins, Vol. 7: Food Poisoning. Tu, A. T., editor. New York: Marcel Dekker, pp. 237-262.
37. Huxtable, R. H. (1999). The safety of botanicals: A historic perspective. In Botanical Medicine. Eshkinazi, D., editor. New York: Mary Ann Liebert, pp. 87-101.
38. Kennedy, A. (2006). Nutrition claims in Canada: A primer. Available: http://www4.agr.gc. ca/AAFC-AAC/display-afficher.do?id=1172766094272&lang=e. Accessed June 10, 2008.
39. Lavy, T., Haran, B., Shemer, J., and Shani, S. (2000). Regulation of natural medicines in Israel and abroad. Harefuah, 139, 339-344, 408, 407. Available: www.heilpflanzenwelt. de/science/2000/11341206.htm. Accessed Oct. 16, 2007.
40. Lefevre, H. (1982). Immunohamolitische anamie nach genuss des kahlen krempling (Paxillus involutus). Deutsche medizinische Wochenschrift, 107, 1734.
41. McNamara, H. S. (1999). Dietary supplement legislation. In BotanicalMedicine. Eshkinazi, D., editor. New York: Mary Ann Liebert, pp. 199-204.
42. Mizuno, T. (1999). The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan (Review). International Journal of Medicinal Mushrooms, 1, 9-31.
43. Natural Products Association (2007). Natural nutritional supplements historical background. Available: www.naturalproductsassoc.org. Accessed Oct. 16, 2007.
44. New Zealand Food Safety Authority (NZFSA) (2005). Food safety; Briefing for incoming ministers.Available: www.maf.govt.nz/mafnet/publications/2005-briefing-for-incomingministers/ food-safety-briefing.pdf. Accessed Oct. 16, 2007.
45. Ohtsuka, S., Ueno, S., Yoshikumi, C., Hirose, F., Ohmura, Y., Wada, T., Fujii, T., and Takahashi E. (1977). Polysaccharides and method for producing same. U.S. Patent 4,051,314, Sept. 27, 1977.
46. Pointing, S. B., Jones, E. B. G., and Vrijmoed, L. L. P. (2000). Optimizations of laccase production by Pycnoporus sanguineus in submerged liquid culture. Mycologia, 92, 139-144.
47. Ross, A. E., Nagel, D. L., and Toth, B. (1982). Evidence for the occurrence and formation of diazonium ions in the Agaricus bisporus mushroom and its extracts. Journal of Agricultural and Food Chemistry, 30, 521-525.
48. Santillo, H. (1993). Natural Healing with Herbs. Prescott, AZ: Hohm Press. Schmidt, J., Hartmann, W., Wurstlin, A., and Deicher, H. (1971). Akutes Nierenversagen durch immunhamolitische Anamie nach Genuss des Kahlen Kremplings (Paxillus involutus). Deutsche Medizinische Wochenschrift, 96, 1188-1191.
49. Schmidt J., Hartmann, W., Wurstlin, A., and Deicher, H. (1971). Akutes Nierenversagen durch immunhamolitische Anamie nach Genuss des Kahlen Kremplings (Paxillus involutus). Deutsche Medizinische Wochenschrift
50. Shimizu, T. (2003). Health claims on functional foods: The Japanese regulations and an international comparison. Nutrition Research Reviews, 16, 241-252.
51. Smith, B. L., Marcotte, M., and Harrison, G. (1996). A comparative analysis of the regulatory framework affecting functional food development and commercialization in Canada, Japan, the European Union and the United States of America. Available: dsp-psd.communication.gc.ca/Collection/WWW96-19E.pdf. Accessed Oct. 16, 2007.
52. Smith, J. E., Rowan, N. J., and Tan, K. K. (2000). Functional food science and the medicinal mushrooms. International Journal of Medicinal Mushrooms, 2, 277-285.
53. Stamets, P. (2000). Growing Gourmet and Medicinal Mushrooms, 3rd ed. Berkeley: Ten Speed, p. 574.
54. Stamets, P. (2002). MycoMedicinals: An Informational Treatise on Mushrooms, 3rd ed. Olympia: MycoMedia Productions, p. 96.
55. State Services Commission (2006). Machinery of government review of the New Zealand Food Safety Authority. Available: http://www.ssc.govt.nz/display/document.asp?DocID D 5401. Accessed Oct. 16, 2007.
56. U.S. Department of Health and Human Services (DHHS) (2006). Food and Drug Administration. Conventional foods being marketed as "functional foods"; public hearing; request for comments. Available: www.fda.gov/OHRMS/DOCKETS/98fr/06-8895.htm. Accessed Oct. 16, 2007.
57. U.S. Federal Trade Commission (FTC) (2001). Dietary supplemets: An advertising guide for industry. Available: www.ftc.gov/bcp/conline/pubs/buspubs/dietsupp.pdf. Accessed Oct. 16, 2007.
58. U.S. Food and Drug Administration (FDA) (2000). Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, 21 CFR part 101, Docket No.98N-0044. Available: www.fda.gov/OHRMS/DOCKETS/98fr/oc99257.pdf. Accessed Oct. 16, 2007.
59. U.S. Food and Drug Administration (FDA) (2004). Guidance for Industry: Botanical Drug Products. Available: www.fda.gov/cder/guidance/4592fnl.pdf. Accessed Oct. 16, 2007.
60. U.S. Government Accountability Office (GAO) (2005). Food safety; experiences of seven countries in consolidating their food safety systems. GAO Report to Congressional Requesters. Available: www.gao.gov/new.items/d05212.pdf. Accessed Oct. 16, 2007. Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60, 258-274.
61. Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology
62. Wasser, S. P., Didukh, M.Y., and Nevo, E. (2004). Dietary supplements from culinary-medicinal mushrooms: A variety of regulations and safety concerns for the 21st century. International Journal of Medicinal Mushrooms, 6, 231-248.
63. Wasser, S. P., Nevo, E., Sokolov, D., Reshetnikov, S., and Timor-Tismenetsky, M. (2000a). Dietary supplements from medicinal mushrooms: Diversity of types and variety of regulations. International Journal of Medicinal Mushrooms, 2, 1-19.
64. Wasser, S. P., Nevo, E., Sokolov, D., and Timor-Tismenetsky, M. (2000b). The regulation of dietary supplements from medicinal mushrooms. In Science and Cultivation of Edible Fungi. Van Griensven, L. J. L. D., editor. Rotterdam: A. A. Balkema, pp. 789-801.
65. Wasser, S. P. and Reshetnikov, S. V. (2002a). Process for producing, method and composition of glucuronoxylomannan as a nutriceutical agent from higher Basidiomycetes mushrooms. U.S. Patent 6,383,799 B1, May 7, 2002.
66. Wasser, S. P. and Reshetnikov, S. V. (2002b). For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged cultures. U.S. Patent 6,362,397 B1, Mar. 26, 2002.
67. Wasser, S. P. and Reshetnikov, S. V. (2002c). Process for producing, methods and composition of cholesterol lowering agents from higher Basidiomycetes mushrooms. U.S. Patent 6,372,462 B2, Apr. 16, 2002.
68. Wasser, S. P., Reshetvikov, S. V., Solomko, E. F., Buchalo, A. S., and Nevo, E. (2002). For higher Basidiomycetes mushrooms grown as biomass in submerged culture. U.S. Patent 6,372,964 B1, Apr. 16, 2002.
69. Wasser, S. P., Sokolov, D., Nevo, E., Reshetnikov, S. and Timor-Tismenetsky, M. (2001). Dietary supplements from medicinal mushrooms: How we are going to ensure their quality and safety. International Journal of Medicinal Mushrooms, 3, 94.
70. Wasser, S. P. and Weis, A. L. (1999a). Medicinal properties of substances occurring in higher basidiomycetes mushrooms: Current perspectives (Review). International Journal of Medicinal Mushrooms, 1, 31-62.
71. Wasser, S. P. andWeis, A. L. (1999b). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Critical Reviews in Immunology, 19, 65-96.
72. World Health Organization (WHO) (1982). Evaluation of certain food additives and contaminants. 26th Report of the Joint FAO/WHO Expert Committee of Food Additives. Technical Report Series No. 683. Geneva: WHO.
73. World Health Organization (WHO) (1991). World Health Organization Programme on Traditional Medicines. Guidelines for the Assessment of Herbal Medicines. Geneva: WHO Reprinted in HerbalGram, 28, 17-20, 1993. Available: http://content. herbalgram.org/wholefoodsmarket/herbalgram/articleview.asp?a=275.
74. Zeisel, S. (1999). Regulation of "nutraceuticals." Science, 285, 1853-1855.